News Search Results
Oct 29, 2025, 08:30 ET Miami Biotech Collective Introduces Board of Advisors and Women's Leadership Council to Shape South Florida's Biotech Future
companies, careers, and innovation thrive. Together, alongside local and statewide partners, we are positioning South Florida as a leading hub for biotechnology. Learn more at
More news about: Miami Biotech Collective
Oct 29, 2025, 08:05 ET Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update
About Rigel Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders
More news about: Rigel Pharmaceuticals, Inc.
Oct 29, 2025, 08:00 ET Numerion Labs Publishes Breakthrough AI Research on Ultra-Fast Screening of Hyper-Scalable Virtual Libraries with NVIDIA
targets, including kinases, GPCRs, proteases and nuclear receptors. These advances have the potential to fundamentally reshape how pharmaceutical and biotechnology companies approach hit discovery by enabling comprehensive, real-time exploration of chemical space. This, in turn, can accelerate progression to
More news about: Numerion Labs
Oct 29, 2025, 07:05 ET REGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2025 Financial Results and Operational Highlights
advised to join 15 minutes prior to the start time. ABOUT REGENXBIO Inc. REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field
More news about: REGENXBIO Inc.
Oct 29, 2025, 07:00 ET Inari Appoints Lisa Nunez Safarian Chief Executive Officer
Sana Biotechnology,
More news about: Flagship Pioneering
Oct 29, 2025, 07:00 ET LillyDirect and Walmart Pharmacy launch first retail pick-up option with direct-to-consumer pricing for Zepbound
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Oct 29, 2025, 06:30 ET Immunic to Participate in Industry and Investor Conferences in November
Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today
More news about: Immunic, Inc.
Oct 29, 2025, 05:01 ET IASO Bio Partners with Korea's GC Cell to Bring CAR-T Therapy to Korea
About IASO Biotechnology IASO Biotechnology is a China-based biopharmaceutical company dedicated to the discovery, development, production and commercialization
More news about: IASO Bio
Oct 29, 2025, 02:59 ET MGI Tech Announces Exclusive Licensing Agreement with Swiss Rockets AG to Globalize Proprietary CoolMPS™ Sequencing Technology
focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and a full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare, and various
More news about: MGI TECH
Oct 29, 2025, 02:03 ET Insilico Showcases Advanced Generative Biologics Engine in Breakthrough 72-Hour Peptide Design Targeting GLP1R for Cardiometabolic Disease
critical health challenges. In alignment with this year's theme of "Diabetes and Well-being," Insilico Medicine, a clinical-stage biotechnology company driven by generative artificial intelligence (AI), is harnessing its proprietary AI engine
More news about: Insilico Medicine
Oct 28, 2025, 22:31 ET "Korea Night" to Bring Global Bio Leaders Together at BIO Europe 2025
opening day of BIO Europe 2025—the largest biotechnology partnering conference in Europe—welcoming participants from across Europe and around the world. Since its launch in 1995, BIO Europe has become one of the world's leading biotechnology partnering events, alongside BIO USA. This
More news about: Korea Night
Oct 28, 2025, 19:00 ET Pinetree Therapeutics Raises $47 Million in Oversubscribed Series B to Advance Next-Generation Protein Degraders in Oncology
CAMBRIDGE, Mass., Oct. 28, 2025 /PRNewswire/ -- Pinetree Therapeutics, a preclinical-stage biotechnology company pioneering targeted protein degraders for drug-resistant cancers, announced the successful closing of an oversubscribed $47 million Series
More news about: PineTree Therapeutics
Oct 28, 2025, 18:00 ET Nektar to Announce Financial Results for the Third Quarter on Thursday, November 6, 2025, After Close of U.S.-Based Financial Markets
About Nektar Therapeutics Nektar Therapeutics is a clinical-stage biotechnology company focused on developing treatments that address the underlying immunological dysfunction in autoimmune and chronic inflammatory diseases.
More news about: Nektar Therapeutics
Oct 28, 2025, 17:31 ET CAR T-cell Therapy Market Forecasts Indicate Strong Growth Trajectory in the 7MM During the Forecast Period (2025-2034) | DelveInsight
Inc, Autolus Therapeutics, Sana Biotechnology, Orgenesis, CARsgen, TILT Biotherapeutics, Poseida Therapeutics, Precision BioSciences, Novartis, Kyverna Therapeutics, Hrain Biotechnology, UTC Therapeutics, Kiromic, Suzhou Fundamenta Therapeutics, Gracell Biotechnology, Innovent Biologics, Nanjing IASO
More news about: DelveInsight Business Research, LLP
Oct 28, 2025, 14:30 ET Lilly partners with NVIDIA to build the industry's most powerful AI supercomputer, supercharging medicine discovery and delivery for patients
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Oct 28, 2025, 12:56 ET NABR: New review of long-tailed macaque population recommends two steps for accurate reassessment of long-tailed macaque global population
research, education, and testing. Members include more than 340 universities, medical and veterinary schools, teaching hospitals, pharmaceutical and biotechnology companies, patient groups, and academic and professional societies who rely on humane and responsible animal research to advance global human and
More news about: National Association for Biomedical Research
Oct 28, 2025, 12:04 ET NABR: New review of long-tailed macaque population recommends two steps for accurate reassessment of long-tailed macaque global population
research, education, and testing. Members include more than 340 universities, medical and veterinary schools, teaching hospitals, pharmaceutical and biotechnology companies, patient groups, and academic and professional societies who rely on humane and responsible animal research to advance global human and
More news about: National Association for Biomedical Research
Oct 28, 2025, 10:47 ET Tsingke Biotech Showcased AI-Powered Biomanufacturing Solutions at 2025 Festival of Biologics
About Tsingke Beijing Tsingke Biotech Co., Ltd. is a leading biotechnology company providing comprehensive solutions for research and therapeutic development. With expertise in molecular biology, genetics, and protein science,
More news about: Beijing Tsingke Biotech Co., Ltd.
Oct 28, 2025, 10:47 ET Tsingke Biotech Showcased AI-Powered Biomanufacturing Solutions at 2025 Festival of Biologics
About Tsingke Beijing Tsingke Biotech Co., Ltd. is a leading biotechnology company providing comprehensive solutions for research and therapeutic development. With expertise in molecular biology, genetics, and protein science,
More news about: Beijing Tsingke Biotech Co., Ltd.
Oct 28, 2025, 10:15 ET Cell-free Protein Synthesis Market worth $308.9 million by 2030 with 7.3% CAGR | MarketsandMarkets™
users, and support high-throughput research and drug discovery projects. The demand for services is also increasing because more pharmaceutical and biotechnology companies, academic researchers, and diagnostic developers are outsourcing, relying on specialized providers for quick turnaround, technical expertise,
More news about: MarketsandMarkets
Oct 28, 2025, 10:00 ET Signios Bio and Illumina Announce Winners of the Illumina-Signios Bio Proteomics Grant Program
Signios Biosciences ("Signios Bio"), a science-first biotechnology company leading in multiomics and AI-powered bioinformatics, in collaboration with
More news about: Signios Bio
Oct 28, 2025, 10:00 ET Lilly announces roster of Team USA athletes for the Olympic and Paralympic Games Milano Cortina 2026, pledges to translate U.S. Olympic and Paralympic milestones into meaningful community impact
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Oct 28, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Jasper Therapeutics, Inc. and Certain Officers - JSPR
here for information about joining the class action] Jasper, a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria ("CSU"), Chronic Inducible
More news about: Pomerantz LLP
Oct 28, 2025, 09:58 ET Resonant to Present at Society for Neuroscience (SfN) Annual Meeting
PLEASANT GROVE, Utah, Oct. 28, 2025 /PRNewswire/ -- Resonant, a biotechnology company advancing native methylation sequencing tools for detecting and monitoring neurodegenerative disease, announced that it will deliver a nanosymposium
More news about: Resonant
Oct 28, 2025, 09:30 ET ObvioHealth and Vaxxas Sign Multi-Year Agreement to Power Needle-Free Vaccination Technology Trials with ObvioGo®
Vaxxas, a clinical-stage biotechnology company pioneering a needle-free vaccination delivery technology. Under the agreement, Vaxxas has selected ObvioGo® as its preferred digital clinical
More news about: ObvioHealth